Nivolumab
Virus
The First Affiliated Hospital of Bengbu Medical Universitymonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Virus cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
rt001 The First Affiliated Hospital of Bengbu Medical University | Phase 1 | CC |
G 207 M.D. Anderson Cancer Center | Phase 1 | CC |
Sodium Chloride University of Edinburgh | N/A | D |
Same molecule, other indications
Nivolumab is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →